M J van de Vijver Selected Research

M J van de Vijver Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2000
13	Neoplasms (Cancer) 04/2022 - 03/2000
3	Neoplasm Metastasis (Metastasis) 04/2019 - 04/2001
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2008 - 02/2001
2	Carcinoma (Carcinomatosis) 01/2014 - 04/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018
1	Polyps 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Ovarian Epithelial Carcinoma 01/2014
1	Triple Negative Breast Neoplasms 04/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2009
1	Esophageal Neoplasms (Esophageal Cancer) 12/2009
1	Lymphatic Metastasis 04/2006
1	Osteosarcoma (Osteogenic Sarcoma) 05/2004
1	Ductal Carcinoma 02/2001

Drug/Important Bio-Agent (IBA)

5	Estrogen ReceptorsIBA 04/2022 - 03/2000
5	Progesterone Receptors (Progesterone Receptor)IBA 07/2015 - 03/2000
4	Messenger RNA (mRNA)IBA 04/2019 - 07/2001
3	AnthracyclinesIBA 07/2011 - 07/2001
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2006 - 03/2000
3	Fluorouracil (Carac)FDA LinkGeneric 04/2006 - 03/2000
2	PlatinumIBA 01/2014 - 07/2011
2	Alkylating AgentsIBA 07/2011 - 04/2006
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2011 - 04/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2011 - 04/2011
2	Epirubicin (Ellence)FDA LinkGeneric 04/2006 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 04/2004 - 03/2000
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Phenobarbital (Luminal)FDA Link 04/2019
1	Circulating Tumor DNAIBA 12/2017
1	Calcibiotic Root Canal SealerIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Hormones (Hormone)IBA 07/2015
1	HLA-G Antigens (HLA G)IBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Estrogen Receptor alphaIBA 12/2013
1	human ERBB2 proteinIBA 12/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2011
1	Histones (Histone)IBA 12/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2009
1	Histone DemethylasesIBA 12/2009
1	Lysine (L-Lysine)FDA Link 12/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2008
1	Androgen Receptors (Androgen Receptor)IBA 01/2008
1	Cadherins (E-Cadherin)IBA 01/2008
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2008
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2008
1	Keratins (Keratin)IBA 01/2008
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2006
1	Tamoxifen FDA LinkGeneric 04/2006
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 04/2006
1	Carboplatin (JM8)FDA LinkGeneric 04/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2004
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2001
1	Epidermal Growth Factor (EGF)IBA 01/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2000

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 04/2019 - 03/2000
6	Therapeutics 08/2012 - 03/2000
4	Neoadjuvant Therapy 04/2011 - 05/2002
3	Radiotherapy 04/2006 - 04/2001
2	Adjuvant Chemotherapy 04/2010 - 11/2006
1	Ovariectomy (Oophorectomy) 04/2004
1	Salpingo-oophorectomy 04/2004
1	Induction Chemotherapy 05/2002